Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Duloxetine (Primary) ; Apomorphine; Levodopa
- Indications Neurological disorders; Parkinson's disease
- Focus Pharmacodynamics
- Acronyms DOULOX
- 21 Feb 2017 Status changed from recruiting to completed.
- 10 Jun 2015 Planned End Date changed from 1 Jun 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 09 Dec 2013 Planned end date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.